JP2023527612A5 - - Google Patents
Info
- Publication number
- JP2023527612A5 JP2023527612A5 JP2022551351A JP2022551351A JP2023527612A5 JP 2023527612 A5 JP2023527612 A5 JP 2023527612A5 JP 2022551351 A JP2022551351 A JP 2022551351A JP 2022551351 A JP2022551351 A JP 2022551351A JP 2023527612 A5 JP2023527612 A5 JP 2023527612A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- pain
- cbga
- immune cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062981424P | 2020-02-25 | 2020-02-25 | |
| US62/981,424 | 2020-02-25 | ||
| US202063072806P | 2020-08-31 | 2020-08-31 | |
| US63/072,806 | 2020-08-31 | ||
| PCT/US2021/019474 WO2021173718A1 (en) | 2020-02-25 | 2021-02-24 | Cannabinoid compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023527612A JP2023527612A (ja) | 2023-06-30 |
| JP2023527612A5 true JP2023527612A5 (https=) | 2024-03-04 |
Family
ID=77490171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551351A Pending JP2023527612A (ja) | 2020-02-25 | 2021-02-24 | カンナビノイド組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230091336A1 (https=) |
| EP (1) | EP4110045A4 (https=) |
| JP (1) | JP2023527612A (https=) |
| AU (1) | AU2021227227A1 (https=) |
| CA (1) | CA3172868A1 (https=) |
| WO (1) | WO2021173718A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202101732D0 (en) * | 2021-02-08 | 2021-03-24 | Tts Pharma Ltd | A cannabinoid mixture |
| EP4415697A4 (en) * | 2021-10-13 | 2025-08-20 | Portland Tech Holdings Llc | HEMP EXTRACT FOR THE TREATMENT OF PAIN, CANCER AND EPILEPSY IN ANIMALS |
| US12440454B2 (en) | 2022-02-01 | 2025-10-14 | Portland Technology Holdings Llc | Pharmaceutical compositions containing hemp extract for administration to felines and related methods |
| WO2026038872A1 (ko) * | 2024-08-13 | 2026-02-19 | 주식회사 네오켄바이오 | 신규한 화합물 및 이의 용도 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1559423A1 (en) * | 2004-02-02 | 2005-08-03 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Medicinal acidic cannabinoids |
| GB2527590A (en) * | 2014-06-27 | 2015-12-30 | Otsuka Pharma Co Ltd | Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer |
| US10857107B2 (en) * | 2017-02-01 | 2020-12-08 | Gbs Global Biopharma, Inc. | Cannabinoid-containing complex mixtures for the treatment of mast cell-associated or basophil-mediated inflammatory disorders |
| EP3592346A4 (en) * | 2017-03-05 | 2020-12-30 | The State of Isreal, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER |
| JP2020520966A (ja) * | 2017-05-22 | 2020-07-16 | ジービーエス グローバル バイオファーマ，インコーポレイテッド | Ｔｒｐｖ１を標的にするミルセン及びカンナビノイド含有組成物 |
| WO2019071302A1 (en) * | 2017-10-09 | 2019-04-18 | The University Of Sydney | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING EPILEPSY CRISES |
| US10751380B2 (en) * | 2018-03-08 | 2020-08-25 | Alexander Kariman | Compound and method for treating spasms, inflammation and pain |
| AU2019251357B2 (en) * | 2018-04-09 | 2023-10-05 | Portland Technology Holdings Llc | Hemp extract for treatment of pain in animals |
| JP2021524465A (ja) * | 2018-05-22 | 2021-09-13 | ジービーエス グローバル バイオファーマ，インコーポレイテッド | Ｔｒｐｖ１モジュレーションに使用するためのカンナビノイド及び／又はテルペン |
| EP3813823A4 (en) * | 2018-06-28 | 2022-08-10 | Canopy Growth Corporation | COMPOSITIONS AND METHODS FOR AGONIZING THE CB2 RECEPTOR |
-
2021
- 2021-02-24 EP EP21760253.1A patent/EP4110045A4/en not_active Withdrawn
- 2021-02-24 JP JP2022551351A patent/JP2023527612A/ja active Pending
- 2021-02-24 US US17/904,934 patent/US20230091336A1/en active Pending
- 2021-02-24 AU AU2021227227A patent/AU2021227227A1/en not_active Abandoned
- 2021-02-24 WO PCT/US2021/019474 patent/WO2021173718A1/en not_active Ceased
- 2021-02-24 CA CA3172868A patent/CA3172868A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023527612A5 (https=) | ||
| ARAKAWA et al. | Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing | |
| Henrotin et al. | Natural products for promoting joint health and managing osteoarthritis | |
| Ordooei Javan et al. | A review on colistin nephrotoxicity | |
| Rosa et al. | Vitexin reduces neutrophil migration to inflammatory focus by down-regulating pro-inflammatory mediators via inhibition of p38, ERK1/2 and JNK pathway | |
| Morgera et al. | Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure | |
| Zhou et al. | Curcumin inhibits placental inflammation to ameliorate LPS-induced adverse pregnancy outcomes in mice via upregulation of phosphorylated Akt | |
| US20050147675A1 (en) | Composition for the treatment and prevention of endothelial dysfunction | |
| Ma et al. | Thiamine alleviates high-concentrate-diet-induced oxidative stress, apoptosis, and protects the rumen epithelial barrier function in goats | |
| Gunasekaran et al. | Hyaluronan 35 kDa enhances epithelial barrier function and protects against the development of murine necrotizing enterocolitis | |
| Bak et al. | Effects of dietary supplementation of glucosamine sulfate on intestinal inflammation in a mouse model of experimental colitis | |
| KR20190095937A (ko) | 설페이트화된 다당류를 포함하는 조성물 | |
| Ikewaki et al. | Hepatoprotective effects of Aureobasidium pullulans derived β 1, 3–1, 6 glucans in a murine model of non-alcoholic steatohepatitis | |
| US20180280464A1 (en) | Compositions and Methods for Pain Relief | |
| AU2025234176B2 (en) | Treatment for Coronavirus infection and associated cytokine toxicity | |
| Wang et al. | Florfenicol induces renal toxicity in chicks by promoting oxidative stress and apoptosis | |
| Zhou et al. | Supplementation of the diet with Salecan attenuates the symptoms of colitis induced by dextran sulphate sodium in mice | |
| Raj et al. | The effects of oat ingredients on blood pressure in spontaneously hypertensive rats | |
| Motavallian et al. | An investigation of the anti-inflammatory effects of gabapentin on acetic acid-induced colitis in rats | |
| Ismaiel et al. | Effects of hypercapnia and hypercapnic acidosis on attenuation of ventilator-associated lung injury | |
| JP2022521711A5 (https=) | ||
| US20120244226A1 (en) | Treatment composition and method | |
| EP4125835A1 (en) | Methods and compositions for treating or preventing an inflammatory condition | |
| JP2022521896A5 (https=) | ||
| Ecelbarger et al. | The effect of chronic candesartan therapy on the metabolic profile and renal tissue cytokine levels in the obese Zucker rat |